中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance

文献类型:期刊论文

作者Zhou, Lei1,2,3; Wang, Hao3; Li, Yaping1,2
刊名THERANOSTICS
出版日期2018
卷号8期号:4页码:1059-1074
关键词multidrug resistance cancer tumor microenvironment stimuli-responsive nanomedicines chemotherapy
ISSN号1838-7640
DOI10.7150/thno.22679
文献子类Review
英文摘要Chemotherapy is still a main option for cancer therapy, but its efficacy is often unsatisfying due to multidrug resistance (MDR). The tumor microenvironment is considered a dominant factor causing MDR. Stimuli-responsive nanomedicines exhibit many superiorities for reversal of MDR. As smart systems, stimuli-responsive nanomedicines are desirable for achieving site-specific accumulation and triggered drug release in response to slight changes in physicochemical properties in pathological conditions or to exogenous stimuli. In this review, we highlight the current progress of various nanomedicines with different stimuli-responsive capabilities for overcoming MDR. The materials, design, construction as well as efficacy in overcoming MDR of these nanomedicines are discussed. Eventually, we look forward to forthcoming intelligent nanoparticle systems with new mechanisms to deliver drugs for practical applications in conquering cancer MDR.
WOS关键词MESOPOROUS SILICA NANOPARTICLES ; ANTICANCER DRUG-DELIVERY ; P-GLYCOPROTEIN INHIBITOR ; WALLED CARBON NANOTUBES ; THERAPY IN-VITRO ; BREAST-CANCER ; CO-DELIVERY ; PHOTODYNAMIC THERAPY ; HYALURONIC-ACID ; TUMOR MICROENVIRONMENT
资助项目National Natural Science Foundation of China[81521005] ; National Natural Science Foundation of China[81630052] ; National Natural Science Foundation of China[81690265] ; Key scientific research program of CAS[QYZDJ-SSW-SMC020]
WOS研究方向Research & Experimental Medicine
语种英语
WOS记录号WOS:000419234800013
出版者IVYSPRING INT PUBL
源URL[http://119.78.100.183/handle/2S10ELR8/272348]  
专题药物制剂研究中心
中科院受体结构与功能重点实验室
新药研究国家重点实验室
通讯作者Li, Yaping
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Pharmaceut, 501 Haike Rd, Shanghai 201203, Peoples R China;
2.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, 501 Haike Rd, Shanghai 201203, Peoples R China;
3.China State Inst Pharmaceut Ind, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Zhou, Lei,Wang, Hao,Li, Yaping. Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance[J]. THERANOSTICS,2018,8(4):1059-1074.
APA Zhou, Lei,Wang, Hao,&Li, Yaping.(2018).Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance.THERANOSTICS,8(4),1059-1074.
MLA Zhou, Lei,et al."Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance".THERANOSTICS 8.4(2018):1059-1074.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。